title: [Adherence and chronic disease: what's about osteoporosis].
abstract: Osteoporosis is a silent chronic disease. The human, medical and economic impacts, as well as the easy access to the screening and specific treatments incite us to introduce a treatment as soon as this one is justified. The maximal efficiency of treatments is possible only if the therapeutic adherence (which includes compliance and persistence) is good. Regrettably, as frequently in the chronic diseases, this one is often bad. It can be strengthened by a better patient's education and information, a better follow-up, but also by a today available variety of treatments.
authors.affiliation: Service de rhumatologie, médecine physique et rééducation et Centre des maladies osseuses, Hôpital orthopedique CHUV, 1011 Lausanne. berengere.aubry@chuv.ch
authors.forename: Bérengère
authors.initials: B
authors.lastname: Aubry-Rozier
authors.forename: Olivier
authors.initials: O
authors.lastname: Lamy
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D055118:Medication Adherence; D010024:Osteoporosis / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D010353:Patient Education as Topic; D012307:Risk Factors; D013997:Time Factors
chemical_list: D050071:Bone Density Conservation Agents